EU parliament extends support to India-South Africa COVID-19 vaccine patent waiver
EU Parliament extends support to India-South Africa for COVID-19 vaccine patent waiver that will help in the large-scale production of the vaccine.
Full Article
EU parliament extends support to India-South Africa COVID-19 vaccine patent waiver
DNA
0 shares
1 views
You might like
Related news coverage
Getting Trade Policy Right Is Crucial To Global COVID-19 Vaccination – Analysis
Eurasia Review
By Ken Heydon*
The death rate in India from COVID-19 has reached alarming levels and that’s intensified attention on..
-
The right incentives for global vaccine access
MENAFN.com
-
Covid vaccine: WTO's TRIPS Council to discuss revised proposal of IPR waiver
IndiaTimes
-
India's push for COVID vaccine patent waiver hits EU roadblock
Deutsche Welle
-
Access to COVID vaccine patents is not the same as access to vaccines
Deutsche Welle
Advertisement
More coverage
Africa The Next Centre For Manufacturing COVID Drug?
Eurasia Review
By Lisa Vives*
For a while, Africa appeared to be losing the fight to build manufacturing capacity for the production of..
-
UK called to support proposal to waive patent protection for COVID-19 vaccines
Proactive Investors
-
EU sceptical of US push to lift Covid vaccine patents
MENAFN.com
-
PM Modi asks EU to back India, South Africa on patent waiver for Covid vaccines
IndiaTimes
-
PM Modi asks support for COVID vaccine patent waiver, EU extends solidarity
Zee News